首页> 美国政府科技报告 >New Trends in Escherichia coli O111:B4 J5 Mutant (Rc chemotype) VaccineDevelopment for Use in Gram-Negative Bacillary Sepsis
【24h】

New Trends in Escherichia coli O111:B4 J5 Mutant (Rc chemotype) VaccineDevelopment for Use in Gram-Negative Bacillary Sepsis

机译:大肠杆菌O111的新趋势:B4 J5突变体(Rc化学型)疫苗开发用于革兰氏阴性细菌性脓毒症

获取原文

摘要

In the course of our studies on the immunotherapy of gram%negativ% bacterialsepsis, we devised an animal model of sepsis which closely mimicked the clinical presentation of sepsis in humans in both the kinetics and level of bacteremia observed as well as in the cytokine profile generate%.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号